Elicera Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	167	253	59	90	70	99
Market Cap Growth	-39.78%	332.31%	-35.03%	29.73%	-29.98%	-
Enterprise Value	149.31	228.51	32.21	60.82	25.71	46.91
Last Close Price	2.51	5.22	1.67	4.56	3.52	5.02
PS Ratio	15.72	23.34	8.22	8.03	54.32	169175.00
PB Ratio	9.13	10.85	2.82	5.50	2.12	1.90
P/TBV Ratio	6.64	10.24	2.54	5.50	2.50	1.72
EV/Sales Ratio	14.04	21.05	4.52	5.42	20.08	79919.10
Net Debt / Equity Ratio	-0.98	-1.06	-1.27	-1.79	-1.34	-1.00
Net Debt / EBITDA Ratio	1.19	1.39	1.57	1.72	2.27	4.00
Net Debt / FCF Ratio	1.01	1.15	1.13	1.97	5.11	4.00
Asset Turnover	0.44	0.39	0.25	0.29	0.03	0.00
Quick Ratio	7.12	6.13	4.01	2.16	3.27	21.04
Current Ratio	8.04	6.75	4.06	2.19	3.39	21.68
Return on Equity (ROE)	-69.38%	-78.88%	-86.68%	-66.66%	-45.72%	-42.00%
Return on Assets (ROA)	-62.04%	-65.27%	-58.48%	-44.70%	-38.32%	-38.97%
Return on Capital Employed (ROCE)	-71.96%	-81.32%	-90.83%	-69.49%	-45.54%	-42.00%
Buyback Yield / Dilution	-36.74%	-45.01%	-59.89%	15.31%	-30.38%	-419.70%
Total Shareholder Return	-36.74%	-45.01%	-59.89%	15.31%	-30.38%	-419.70%